Single agent |
Combinations |
a These regimens should be adjusted based on the results of culture and susceptibility testing.
b Empiric regimens with activity against Enterococcus faecalis are preferred for severe or nosocomial infections.
c Antipseudomonal
d The carbapenems and often fluoroquinolones, but not third-generation cephalosporins or β-lactam–β-lactamase inhibitor combinations, are active against ampC β-lactamase-producing and extended-spectrum β-lactamase (ESBL)-producing aerobic–facultative gram-negative bacilli.
![](https://freepngimg.com/download/social_media/63059-media-icons-telegram-twitter-blog-computer-social.png)
Stay updated, free articles. Join our Telegram channel
![](https://clinicalpub.com/wp-content/uploads/2023/09/256.png)
Full access? Get Clinical Tree
![](https://videdental.com/wp-content/uploads/2023/09/appstore.png)
![](https://videdental.com/wp-content/uploads/2023/09/google-play.png)